| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.69 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.29 | 1e-13 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.23 | 3e-11 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.22 | 0.5 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.21 | 8e-10 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.21 | 9e-11 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-06 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.21 | 0.008 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.2 | 0.2 |